In the large intestine HT-29 cell lines, EGCG increased the activity of TfR (transferrin receptor), which is a carrier protein for transferrin, and inhibited the activity of the ferritin-H protein through iron chelating activity in HT-29 colon cancer cells [94]. Here, TFRC is linked to malignant colon neoplasm.